Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Novo Nordisk considers upgrading its New York listing to boost its U.S. profile

Novo Nordisk considers upgrading its New York listing to boost its U.S. profile

智通财经智通财经2026/09/23 04:21
Show original
According to the Financial Times: Novo Nordisk (NVO.US) does not rule out upgrading its listing status in New York, a move aimed at enhancing the Danish weight-loss drug manufacturer's visibility in the US market. Previously, its British competitor AstraZeneca took a similar step earlier this year.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!